Compile Data Set for Download or QSAR
Report error Found 36 Enz. Inhib. hit(s) with all data for entry = 2735
TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377695(US10266496, Example 7)
Affinity DataIC50: 10.9nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377700(US10266496, Example 27)
Affinity DataIC50: 14nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377703(US10266496, Example 30)
Affinity DataIC50: 15nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377690(US10266496, Example 2)
Affinity DataIC50: 19nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377689(US10266496, Example 1)
Affinity DataIC50: 19.6nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377706(US10266496, Example 40)
Affinity DataIC50: 30nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377701(US10266496, Example 28)
Affinity DataIC50: 34nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377702(US10266496, Example 29)
Affinity DataIC50: 34.6nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377702(US10266496, Example 29)
Affinity DataIC50: 38nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377698(US10266496, Example 21)
Affinity DataIC50: 39.5nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377704(US10266496, Example 31)
Affinity DataIC50: 45nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377706(US10266496, Example 40)
Affinity DataIC50: 53.6nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377704(US10266496, Example 31)
Affinity DataIC50: 57.8nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377692(US10266496, Example 4)
Affinity DataIC50: 60.4nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377697(US10266496, Example 18)
Affinity DataIC50: 63.3nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377694(US10266496, Example 6)
Affinity DataIC50: 66.2nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377699(US10266496, Example 25)
Affinity DataIC50: 68nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377697(US10266496, Example 18)
Affinity DataIC50: 70nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377700(US10266496, Example 27)
Affinity DataIC50: 88.8nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377696(US10266496, Example 17)
Affinity DataIC50: 90.2nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377705(US10266496, Example 33)
Affinity DataIC50: 91nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377693(US10266496, Example 5)
Affinity DataIC50: 94.8nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377691(US10266496, Example 3)
Affinity DataIC50: 101nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377705(US10266496, Example 33)
Affinity DataIC50: 102nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377689(US10266496, Example 1)
Affinity DataIC50: 140nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377701(US10266496, Example 28)
Affinity DataIC50: 146nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377699(US10266496, Example 25)
Affinity DataIC50: 164nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377698(US10266496, Example 21)
Affinity DataIC50: 172nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377693(US10266496, Example 5)
Affinity DataIC50: 179nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377703(US10266496, Example 30)
Affinity DataIC50: 179nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377694(US10266496, Example 6)
Affinity DataIC50: 234nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377696(US10266496, Example 17)
Affinity DataIC50: 271nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377692(US10266496, Example 4)
Affinity DataIC50: 499nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377690(US10266496, Example 2)
Affinity DataIC50: 667nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377691(US10266496, Example 3)
Affinity DataIC50: 804nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetSolute carrier family 22 member 12(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377695(US10266496, Example 7)
Affinity DataIC50: 2.88E+3nMAssay Description:a. Construction of a Cell Line Stably Expressing hURAT1hURAT1 plasmid was transfected into HEK293T cell, and a cell line stably expressing hURAT1 was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent